Mark DeLacure, MD

Dr. DeLacure was Chairman of the Division of Head & Neck Surgery and Oncology and Reconstructive Plastic Surgery at the Roswell Park Cancer Institute from 1995-1998. He then joined the faculty of the NYU (New York University) as Chief of the Division of Head & Neck Surgery, through 2019. He was jointly appointed in the Departments of Otolaryngology - Head & Neck Surgery, Neurosurgery, and the Institute of Reconstructive Plastic Surgery (later the Hansjorg Wyss Department of Plastic Surgery) and was granted the George Hall Endowed Chair in Head & Neck Surgery in 2017. He joined the Cleveland Clinic in 2023.

He has performed surgery, primarily in the Mission context, and/or as invited instructor, including complex reconstructive microsurgery cases, all over the world, including India, Kenya, Viet Nam, Haiti and Mongolia. Where will he go next ?

Dr. DeLacure has participated in the mentoring and training of dozens of residents and fellows in all of the above surgical specialties, as well as Residents and Fellows in Orthopaedics (complex approaches to the cervical spine) over a nearly 30-year career. Many have gone on to leadership and prominent positions all over the world, and in hospitals and cancer centers throughout much of New York City.

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2026-02-02, Dr. DeLacure has reported no financial relationship with industry that is applicable to this listing.

In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.